Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

RYAN vs CNM: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CNM Captures Overall Composite Edge (48.9 HOLD vs 40.7 SELL), While RYAN Leads 4–1 on Growth & Valuation Pillars

CNM Overall Winner 6-Pillar Tally: RYAN 4 – 1 CNM (1 Tie) Matrix Metrics: RYAN 6 – 4 CNM

As of Nov 16, 2026, Core & Main, Inc. (CNM) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (48.9/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 4–6 (led by Valuation Multiples), while RYAN wins 4–1 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus CNM at $43.87 (17.0x Forward P/E, 9.6% operating margin).

  • Growth vs. Quality Trade-Off: CNM earns the overall head-to-head edge with a stronger Unified Composite Score (48.9/100 HOLD vs. RYAN 40.7/100 SELL) and 1.10β · 45% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: RYAN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.9); meanwhile CNM is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RYAN vs CNM
RYAN NYSE
Ryan Specialty Holdings, Inc.
Insurance Agents, Brokers & Service
$47.86
+2.07% 1D
Market Cap $11.9B
TTM Revenue $6.20B
Forward P/E 19.7x
Beta / 30D Vol -0.32β · 39% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 22.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 67
RSI-14: 66.9 · SMA20: $45.34 · SMA50: $41.30
CNM NYSE Head-to-Head Winner
Core & Main, Inc.
Wholesale-Durable Goods, Nec
$43.87
-2.51% 1D
Market Cap $8.3B
TTM Revenue $7.70B
Forward P/E 17.0x
Beta / 30D Vol 1.10β · 45% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.2%) with fading momentum, RSI 48
RSI-14: 48.2 · SMA20: $44.45 · SMA50: $42.81

6-Pillar Scorecard Institutional Category Breakdown (RYAN 4 – 1 CNM)

Columns: Metric · RYAN · CNM
1. Valuation Multiples CNM
Forward P/E 19.7x 17.0x
Trailing P/E 58.6x 18.5x
PEG Ratio N/M 1.43x
EV / Revenue 1.9x 1.1x
2. Growth & Scale RYAN
Revenue Growth (YoY) +4.8% +2.5%
Earnings Growth (YoY) +43.1% +9.2%
TTM Revenue (USD) $6.20B $7.70B
Market Cap $11.9B $8.3B
3. Profitability & Quality RYAN
Gross Margin 41.1% 27.0%
Operating Margin 19.8% 9.6%
Net Profit Margin 3.3% 6.0%
Return on Equity (ROE) 25.1% 23.6%
4. Balance Sheet & Cash Flow RYAN
Cash Generation (TTM) $1.77B EBITDA $935M EBITDA
Cash Flow Margin 28.5% EBITDA Mgn 12.1% EBITDA Mgn
Net Cash / Leverage $3.71 Book/Sh · 25.1% ROE $11.01 Book/Sh · 23.6% ROE
Dividend Yield 1.11% None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 29.7% (12th %ile) 31.1% (2nd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Distribution
6. R&D & Supply-Chain Moat RYAN
OpEx & R&D Intensity 21.3% of Rev ($1.32B) 17.4% of Rev ($1.34B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Industrial Distribution Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RYAN (6) vs CNM (4)
Institutional Metric RYAN CNM Criterion Row Edge
Market Capitalization
Scale
$11.9B $8.3B Larger Scale RYAN
Trailing P/E Ratio
Valuation
58.6x 18.5x Lower Multiple CNM
Forward P/E Ratio
Valuation
19.7x 17.0x Lower Multiple CNM
Revenue Growth (YoY)
Growth
+4.8% +2.5% Higher Growth RYAN
Operating Margin (TTM)
Profitability
19.8% 9.6% Higher Margin RYAN
Net Profit Margin
Profitability
3.3% 6.0% Higher Margin CNM
Return on Equity (ROE)
Capital Efficiency
25.1% 23.6% Higher ROE RYAN
52-Week Range Position
Momentum
63% ($29–$59) 22% ($39–$60) Stronger Trend RYAN
Beta / 30D Volatility
Risk Regime
-0.32β · 39% Vol 1.10β · 45% Vol Lower Realized Risk RYAN
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 48.9 / 100 (HOLD) Higher Composite CNM
Trailing 12M Revenue (USD)
Operating Scale
$6.20B $7.70B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.1% 27.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.9x EV/Rev 1.43x PEG · 1.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.77B EBITDA ($3.71 Book/Sh · 25.1% ROE) $935M EBITDA ($11.01 Book/Sh · 23.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RYAN +12.97 pp
RYAN: +17.45% · CNM: +4.48%
3M Horizon RYAN +19.53 pp
RYAN: +16.05% · CNM: -3.48%
6M Horizon RYAN +47.04 pp
RYAN: +42.14% · CNM: -4.9%
1Y Horizon CNM +6.98 pp
RYAN: -15.83% · CNM: -8.85%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYAN vs CNM. Trailing 12-month operating profitability (RYAN 19.8% vs CNM 9.6%) and valuation multiples (RYAN 19.7x vs CNM 17.0x Forward P/E) are benchmarked directly in Pillar 4 below.

RYAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.20B
Gross Margin41.1%
Op. Margin19.8%
ROE / Fwd P/E25.1% · 19.7x
CNM ADR TTM Benchmark FX-Normalized USD
TTM Revenue$7.70B
Gross Margin27.0%
Op. Margin9.6%
ROE / Fwd P/E23.6% · 17.0x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RYAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 29.7%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CNM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 31.1%
IV Percentile 2nd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CNM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RYAN Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment 21.3% of Rev ($1.32B)
90D Engineering Disclosures 0 Published
CNM Moat Profile Scale & Operating Efficiency Moat
Industrial Distribution Operator
Competes within the Industrial Distribution value chain with $8.3B market capitalization and 9.6% operating margin.
OpEx & R&D Reinvestment 17.4% of Rev ($1.34B)
90D Engineering Disclosures 0 Published

Investor FAQ RYAN vs CNM Key Questions & Quantitative Answers

As of Nov 16, 2026, Core & Main, Inc. (CNM) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (48.9/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 4–6 (led by Valuation Multiples), while RYAN wins 4–1 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus CNM at $43.87 (17.0x Forward P/E, 9.6% operating margin). Growth vs. Quality Trade-Off: CNM earns the overall head-to-head edge with a stronger Unified Composite Score (48.9/100 HOLD vs. RYAN 40.7/100 SELL) and 1.10β · 45% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: RYAN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 66.9); meanwhile CNM is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

RYAN leads the Growth & Scale pillar: RYAN posts +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin), compared with CNM at +2.5% YoY revenue growth and +9.2% YoY earnings growth on $7.70B TTM revenue (27.0% gross margin, 9.6% operating margin). On trailing 12-month operating scale, RYAN generates $6.20B in USD-normalized revenue versus $7.70B for CNM. In operating R&D and SG&A reinvestment, RYAN deploys 21.3% of Rev ($1.32B) (0 90-day corporate R&D disclosures) versus 17.4% of Rev ($1.34B) (0 disclosures) for CNM.

CNM screens cheaper on headline valuation multiples. RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin), whereas CNM trades at 17.0x Forward P/E, 18.5x Trailing P/E, 1.43x PEG, and 1.1x EV/Revenue (12.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RYAN (25.1% ROE) versus CNM (23.6% ROE) capital efficiency.

In options market volatility and institutional positioning, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk). By comparison, CNM carries 31.1% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.10β · 45% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.